Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202–9.

Article  PubMed  Google Scholar 

Chan KE, Koh TJL, Tang ASP, Quek J, Yong JN, Tay P, et al. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. J Clin Endocrinol Metab. 2022;107(9):2691–700.

Article  PubMed  Google Scholar 

Li J, Zou BY, Yeo YH, Feng YM, Xie XY, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol. 2019;4(5):389–98.

Google Scholar 

Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138–53.

Article  PubMed  Google Scholar 

Severinsen MCK, Pedersen BK. Muscle-Organ Crosstalk: The Emerging Roles of Myokines (vol 41, pg 594, 2020). Endocr Rev. 2021;42(1):97–9.

Article  Google Scholar 

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300.

Article  PubMed  Google Scholar 

Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship Between Sarcopenia and Nonalcoholic Fatty Liver Disease: The Korean Sarcopenic Obesity Study. Hepatology. 2014;59(5):1772–8.

Article  PubMed  CAS  Google Scholar 

Wang YM, Zhu KF, Zhou WJ, Zhang Q, Deng DF, Yang YC, et al. Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study. Bmc Geriatr. 2021;21(1):55.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gan D, Wang L, Jia MH, Ru Y, Ma YY, Zheng WF, et al. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr. 2020;39(4):1124–30.

Article  PubMed  Google Scholar 

Chung GE, Kim MJ, Yim JY, Kim JS, Yoon JW. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease. J Obes Metab Syndr. 2019;28(2):129–38.

Article  PubMed  PubMed Central  Google Scholar 

Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). J Hepatol. 2015;63(2):486–93.

Article  PubMed  Google Scholar 

Petta S, Ciminnisi S, Di Marco V, Cabibi D, Camma C, Licata A, et al. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharm Ther. 2017;45(4):510–8.

Article  CAS  Google Scholar 

Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123–31.

Article  PubMed  Google Scholar 

Guo W, Zhao X, Miao MY, Liang XR, Li XN, Qin P, et al. Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease. Front Nutr. 2022;9:883015.

Hsieh YC, Joo SK, Koo BK, Lin HC, Kim W. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2021;41(3):494–504.

Article  PubMed  CAS  Google Scholar 

Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH, et al. Sarcopenia Is Associated With Significant Liver Fibrosis Independently of Obesity and Insulin Resistance in Nonalcoholic Fatty Liver Disease: Nationwide Surveys (KNHANES 2008-2011). Hepatology. 2016;63(3):776–86.

Article  PubMed  CAS  Google Scholar 

Kim KH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, et al. Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases. Eur J Gastroen Hepat. 2020;32(1):58–65.

Article  Google Scholar 

Poggiogalle E, Donini LM, Lenzi A, Chiesa C, Pacifico L. Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle. World J Gastroenterol. 2017;23(10):1747–57.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, et al. MRI: the new reference standard in quantifying hepatic steatosis? Gut. 2012;61(1):117–27.

Article  PubMed  Google Scholar 

Gu JL, Liu SS, Du SX, Zhang Q, Xiao JH, Dong QJ, et al. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 2019;29(7):3564–73.

Article  PubMed  Google Scholar 

Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Utility of Magnetic Resonance Imaging Versus Histology for Quantifying Changes in Liver Fat in Nonalcoholic Fatty Liver Disease Trials. Hepatology. 2013;58(6):1930–40.

Article  PubMed  CAS  Google Scholar 

Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol. 2016;65(5):1006–16.

Article  PubMed  PubMed Central  Google Scholar 

Ye J, Wu Y, Li F, Wu T, Shao C, Lin Y, et al. Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction. Therap Adv Gastroenterol. 2019;12:1756284819879047.

Article  PubMed  PubMed Central  Google Scholar 

Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889–919.

Article  PubMed  Google Scholar 

Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10.

Article  PubMed  CAS  Google Scholar 

Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–73.

Article  PubMed  Google Scholar 

Kim G, Lee SE, Lee YB, Jun JE, Ahn J, Bae JC, et al. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. Hepatology. 2018;68(5):1755–68.

Article  PubMed  CAS  Google Scholar 

Dong Z, Luo Y, Zhang ZW, Cai HS, Li YB, Chan T, et al. MR Quantification of Total Liver Fat in Patients with Impaired Glucose Tolerance and Healthy Subjects. Plos One. 2014;9(10):e111283.

Kim M, Shinkai S, Murayama H, Mori S. Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body composition in a community-dwelling older population. Geriatr Gerontol Int. 2015;15(8):1013–22.

Article  PubMed  Google Scholar 

Peniche DBR, Giorguli GR, Aleman-Mateo H. Accuracy of a predictive bioelectrical impedance analysis equation for estimating appendicular skeletal muscle mass in a non-Caucasian sample of older people. Arch Gerontol Geriat. 2015;61(1):39–43.

Article  Google Scholar 

Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M, et al. Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia. Int J Env Res Pub He. 2017;14(7):809.

Article  Google Scholar 

Waxman A, World Health A. WHO global strategy on diet, physical activity and health. Food Nutr Bull. 2004;25(3):292–302.

Article  Google Scholar 

Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.

Article  PubMed  Google Scholar 

Yu KH, Chen DY, Chen JH, Chen SY, Chen SM, Cheng TT, et al. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21(4):772–87.

Article  PubMed  CAS  Google Scholar 

Tamaki N, Munaganuru N, Jung J, Yonan AQ, Loomba RR, Bettencourt R, et al. Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut. 2022;71(5):983–90.

Article  PubMed  CAS  Google Scholar 

Pan XY, Liu WY, Zhu PW, Li G, Tang LJ, Gao F, et al. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male. Hepatol Int. 2022;16(5):1085–93.

Article  PubMed  Google Scholar 

Lee MJ, Kim EH, Bae SJ, Kim GA, Park SW, Choe J, et al. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study. Gut. Liver. 2019;13(1):67.

Google Scholar 

Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in Hiding: The Risk and Consequence of Underestimating Muscle Dysfunction in Nonalcoholic Steatohepatitis. Hepatology. 2017;66(6):2055–65.

Article  PubMed  CAS  Google Scholar 

Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endo. 2014;2(10):819–29.

Article  Google Scholar 

Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocr Metab. 2006;91(12):4753–61.

Article  PubMed  CAS  Google Scholar 

Fujita S, Rasmussen BB, Cadenas JG, Drummond MJ, Glynn EL, Sattler FR, et al. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism